Ambrosia Biosciences Secures $16MM in Series A Financing to Advance Breakthrough Therapies for Obesity
Ambrosia Biosciences secures $16M in Series A funding to advance small molecule therapies for obesity, leveraging the expertise of,,,
Ambrosia Biosciences secures $16M in Series A funding to advance small molecule therapies for obesity, leveraging the expertise of,,,
WSPN is on a mission to transform digital payments with Stablecoin 2.0. By focusing on user-centric value and community-driven governance, they’re making global transactions as easy as sending a text…
Learn how Dispatch uses custom AI solutions to make last-mile delivery more efficient, helping businesses streamline their operations and reduce costs…
Tickeri’s new platform enhances Latin music events across the U.S., offering advanced tools and support to…
Learn how Purpose Rounds™ by Renew Venture Capital empower startups to align their values with community support, making investment opportunities more inclusive and purpose-driven…
Giraffe combines decades of industry expertise with modern technology, offering a comprehensive software suite that addresses the full lifecycle of building design, construction, and…
Henrik.ai by Neuralogics is revolutionizing software creation, empowering anyone to build functional applications without coding knowledge. Learn how this AI tool is…
Revuud simplifies healthcare IT talent management by offering direct access to top professionals, saving organizations time, money, and improving operational efficiency…
D4D Sarl has been granted a patent for the Clockchain, a groundbreaking blockchain-based system that provides a secure and consistent global time source.
Rally OurBus is redefining bus travel with on-demand rides to events and scheduled intercity routes, connecting communities and promoting greener transportation…